Ipsen news | Ipsen Global

Stories

Discover all of the trending stories of Ipsen Group.

Explore more by category

Filter

Period

Filter by

recent search

Showing: 15 of 152 stories

Ipsen's Commitment to Biodiversity  
 –  – 3 mins read

 – 3 mins read

Ipsen’s Commitment to Biodiversity  

Biodiversity encompasses the rich array of species and ecosystems vital for our planet’s health. Yet, human activities have endangered this diversity, jeopardizing not only various species but also our daily lives. Biodiversity is crucial for human health, providing essential services such as pollin


Exploring life and parenthood with Primary Biliary Cholangitis 
 –  – 4 mins read

 – 4 mins read

Exploring life and parenthood with Primary Biliary Cholangitis 

Sandra Silvestri, Executive Vice President & Chief Medical Officer at Ipsen, reflects on the challenges women living with primary biliary cholangitis (PBC) face and why we have big dreams of a better future for PBC.


Improving Diversity in Research and Development to Drive Health Equity
 –  – 4 mins read

 – 4 mins read

Improving Diversity in Research and Development to Drive Health Equity

To mark World Clinical Trials Day, we sat down with Christelle Huguet, Executive Vice President, Head of R&D at Ipsen to explore the importance of diversity from all sides of the research and development process, as we accelerate innovation.  


Progressive Familial Intrahepatic Cholestasis (PFIC): Liver experts discuss early diagnosis and management 
 –  – 2 mins read

 – 2 mins read

Progressive Familial Intrahepatic Cholestasis (PFIC): Liver experts discuss early diagnosis and management 

Progressive Familial Intrahepatic Cholestasis (PFIC) is a rare liver disease that can pose significant challenges, particularly in young children1, but the good news is that there are growing opportunities to manage the disease, slow its progression and improve outcomes.  


2024 Annual General Meeting
 –  – 0 mins read

 – 0 mins read

2024 Annual General Meeting

A replay with complete presentation and Q&A session will be made available soon after the Annual General Meeting.